92 Participants Needed

Exercise Program for Heart Failure

EG
EP
BS
Overseen ByBen Stephenson
Age: 65+
Sex: Any
Trial Phase: Academic
Sponsor: University of Virginia
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

What You Need to Know Before You Apply

What is the purpose of this trial?

This trial aims to determine if a new exercise program, combining aerobic and resistance training, can improve health outcomes for people with heart failure with reduced ejection fraction (HFrEF) more effectively than the current standard exercise routine. Participants will be randomly assigned to one of two groups: one will try the new program (COMBO), and the other will continue with the traditional routine (PRIME). Suitable candidates have heart failure with specific characteristics, such as an ejection fraction under 45% and some limitations in daily activities.

As an unphased trial, this study provides participants the chance to contribute to innovative research that could enhance exercise strategies for heart failure.

Will I have to stop taking my current medications?

The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.

What prior data suggests that this exercise program is safe for individuals with heart failure?

Research has shown that exercise programs like PRIME and COMBO are safe for people with heart failure. In a study of the COMBO program, heart failure patients completed over 60,000 hours of exercise without any exercise-related deaths, indicating the program is well-tolerated.

For PRIME, early studies suggest that older patients with chronic heart failure can manage the exercise routine. Although detailed information on side effects for PRIME remains limited, its testing in trials suggests reasonable safety. Both programs aim to improve health through supervised exercise, which is generally safe.12345

Why are researchers excited about this trial?

Researchers are excited about the exercise programs COMBO and PRIME for heart failure because they offer a new approach to managing the condition. Unlike standard treatments that primarily focus on medications and lifestyle changes, these programs incorporate structured exercise regimens. The PRIME + COMBO approach starts with personalized training followed by progressive whole-body exercises, potentially offering enhanced cardiovascular benefits. Additionally, the COMBO-only program emphasizes continued progressive aerobic and resistance training, which might provide sustained improvements in heart function. These innovative exercise strategies could complement existing therapies and offer a more active way to improve heart health.

What evidence suggests that this trial's exercise programs could be effective for heart failure?

Research shows that exercise programs like the COMBO program, which participants in this trial may receive, can help people with heart failure by improving exercise capacity and enhancing quality of life. Studies have found that it can also improve heart function and reduce hospital visits. The PRIME program, another treatment option in this trial, focuses on a special type of exercise called peripheral remodeling. Early results suggest that PRIME might improve aerobic capacity, which is important for heart health. Both programs aim to support people with heart failure, but PRIME may offer unique benefits in how the body uses oxygen during exercise.16789

Who Is on the Research Team?

Jason David Allen | UVA School of ...

Jason Allen, PhD

Principal Investigator

University of Virginia

Are You a Good Fit for This Trial?

This trial is for individuals over 65 with heart failure and reduced ejection fraction (HFrEF), specifically those who can communicate well, have cardiologist approval, and a hemoglobin level of at least 10.0 g/dL. It's not for people with uncontrolled diabetes, recent heart attacks or embolism, severe valve disease needing surgery, new atrial fibrillation, worsening symptoms in the past few days, significant ischemia during low exercise levels, or certain other acute conditions.

Inclusion Criteria

My cardiologist has approved my participation after reviewing my medical records and examining me.
I can understand and communicate about the study, and I can legally consent.
Your hemoglobin level must be at least 10.0 grams per deciliter.
See 2 more

Exclusion Criteria

I have not had a blood clot in the last 6 weeks.
I have severe narrowing of my aortic valve.
I need surgery for a heart valve problem causing backflow.
See 9 more

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Phase 1: Treatment

Participants undergo 4 weeks of either PRIME or COMBO exercise training

4 weeks

Phase 2: Treatment

All participants undergo 8 weeks of progressive whole-body COMBO training

8 weeks

Follow-up

Participants are monitored for safety and effectiveness after treatment

6 months

What Are the Treatments Tested in This Trial?

Interventions

  • COMBO
  • PRIME
Trial Overview The study compares a novel exercise program called PRIME against the traditional COMBO exercise regimen to see which one leads to better health outcomes for older patients with HFrEF. Participants will be randomly assigned to either the investigational PRIME program or the standard COMBO training.
How Is the Trial Designed?
2Treatment groups
Experimental Treatment
Group I: PRIME + COMBOExperimental Treatment2 Interventions
Group II: COMBO onlyExperimental Treatment1 Intervention

Find a Clinic Near You

Who Is Running the Clinical Trial?

University of Virginia

Lead Sponsor

Trials
802
Recruited
1,342,000+

National Institute on Aging (NIA)

Collaborator

Trials
1,841
Recruited
28,150,000+

National Institutes of Health (NIH)

Collaborator

Trials
2,896
Recruited
8,053,000+

Published Research Related to This Trial

Patients with heart failure, both HFrEF and HFpEF, experience significant reductions in type I muscle fibers and oxidative enzymes, leading to impaired exercise metabolism and intolerance.
Exercise training can improve skeletal muscle function and exercise tolerance in HFrEF patients, while adjunctive strategies like nutritional supplementation show potential but are still in early research stages.
Impaired Exercise Tolerance in Heart Failure: Role of Skeletal Muscle Morphology and Function.Tucker, WJ., Haykowsky, MJ., Seo, Y., et al.[2022]
Exercise training is safe for patients with heart failure and leads to significant improvements in health status and exercise capacity, while also helping to reduce abnormal heart function associated with the condition.
The benefits of exercise training, including a modest reduction in clinical events, are linked to the amount of exercise performed, highlighting the need for future research to determine the best exercise strategies for different patient groups.
Role and benefits of exercise in the management of patients with heart failure.Keteyian, SJ., Fleg, JL., Brawner, CA., et al.[2021]
Recent studies have established effective exercise testing protocols for patients with peripheral arterial disease and congestive heart failure, leading to significant improvements in exercise performance and quality of life.
The improvements in exercise capacity are primarily due to adaptations in skeletal muscle metabolism rather than increases in heart function or blood flow, highlighting the importance of targeted exercise training in these patient populations.
Exercise physiology in cardiovascular diseases.Hiatt, WR.[2019]

Citations

Exercise Training and Heart Failure: A Review of the LiteratureExercise training and cardiac rehabilitation have demonstrated numerous benefits for people with CHF, including improved exercise capacity and QoL.
Exercise Training in Heart Failure: Clinical Benefits and ...Studies of patients with both HFrEF and HFpEF have demonstrated a consistent improvement in cardiorespiratory fitness, as measured by peak VO2, ...
PRIME HFrEF: Novel Exercise for Older Patients With Heart ...The objective of this study is to determine whether PRIME exercise training can outperform traditional (COMBO) exercise training to improve outcomes in HFrEF ...
Efficacy and Safety of Exercise Training in Patients With ...These studies also suggested that exercise training might improve survival and decrease heart failure hospitalizations. Two meta-analyses ...
Impact of exercise training on clinical outcomes and quality ...Exercise training is a beneficial intervention for CHF patients, improving health-related quality of life and reducing hospitalization.
Exercise training in chronic heart failure - PubMed Central - NIHIn their systematic review Smart and Marwick reported no exercise-related deaths during over 60,000 h of exercise training by HF patients [Smart and Marwick, ...
Supervised Exercise Training for Chronic Heart Failure ...This scientific statement critically examines the currently available literature on the effects of exercise-based therapies for chronic stable HFpEF.
HF-ACTION Randomized Controlled Trial - PubMed CentralObjective. To test the efficacy and safety of exercise training among patients with heart failure.
Exercise Training as Therapy for Heart Failure | CirculationExercise training improves exercise intolerance and QOL in patients with chronic stable HFrEF, and has become an accepted adjunct therapy for these patients.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Terms of Service·Privacy Policy·Cookies·Security